Tregitopes are Everywhere

Even in SARS-CoV-2 (COVID-19)

Thank you for choosing to participate in our informational webinar about Tregitopes, a powerhouse of immune tolerance.  

Topics will include the modulation of immune response by IVIG and Tregitopes, the impact of Tregitopes on immunogenicity of biologics and vaccines,  and tools for defining and validating Tregitopes in silico and in vitro

Featured speakers include Dr. Annie De Groot (CEO/CSO, EpiVax, Inc.), Dr. Bruce Mazer (Professor - Department of Pediatrics, McGill University) and Frances Terry (Director of Analysis, EpiVax, Inc.).  

Please extend this invitation to any colleagues or associates you feel would benefit from attending. 

We look forward to "seeing" you Friday June 19, 2020 at 11:00AM EDT.

Signup for the EpiVax newsletter to receive updates from our CEO Dr. Annie De Groot!
* indicates required